Childhood-onset craniopharyngioma - a life-long family burden?
J Clin Endocrinol Metab. 2023 Oct 17:dgad613. doi: 10.1210/clinem/dgad613. Online ahead of print.NO ABSTRACTPMID:37847153 | DOI:10.1210/clinem/dgad613 (Source: The Journal of Clinical Endocrinology and Metabolism)
Source: The Journal of Clinical Endocrinology and Metabolism - October 17, 2023 Category: Endocrinology Authors: Julia Beckhaus Carsten Friedrich Hermann L M üller Source Type: research
Spontaneous or iatrogenic ? Postoperative pseudo aneurysm in craniopharyngioma: Case report
We report a case of a psedoaneurysm of the distal ACA AT A2`-A3 junction in a case of cystic Craniopharyngioma who presented with rupture, 2 weeks after primary surgery. Insight into the probable causes of aneurysm formation and its subsequent rupture and management have been described. (Source: Journal of Pediatric Neurosciences)
Source: Journal of Pediatric Neurosciences - October 17, 2023 Category: Neuroscience Authors: Apinderpreet Singh Tejasvi Singh Randhawa Kirti Gupta Chirag Ahuja Pravin Salunke Source Type: research
The impact of facility type and volume on treatment and overall survival in craniopharyngioma
ConclusionTreatment of craniopharyngioma at HVC compared to LVC is associated with improved OS, lower 30- and 90-day postoperative mortality risk, and more common use of both radiotherapy and endoscopic surgical approach. (Source: Pituitary)
Source: Pituitary - October 17, 2023 Category: Endocrinology Source Type: research
Tocilizumab for the fifth progression of cystic childhood craniopharyngioma —a case report
We present the case of a 15-year-old girl, with a fifth cystic progression of an adamantinomatous craniopharyngioma after multiple surgeries and previous local radiotherapy. She had severe visual impairment, panhypopituitarism including diabetes insipidus, and several components of hypothalamic damage, including morbid obesity and severe fatigue. To prevent further late effects hampering her quality of survival, she was treated biweekly with intravenous tocilizumab, an anti-interleukin-6 agent, which stabilized the cyst for a prolonged time. Based on the biology of adamantinomatous craniopharyngioma, this immune-modulating...
Source: Frontiers in Endocrinology - October 11, 2023 Category: Endocrinology Source Type: research
Xanthogranuloma of the suprasellar region mimicking cystic craniopharyngioma: A case report
CONCLUSION: Although xanthogranuloma is uncommon, it should be included in the differential diagnosis of sellar/suprasellar lesions. Due to its wide range of radiological features that sometimes can mimic other lesions, a definitive diagnosis can only be made postoperatively. Surgical excision is the most accepted treatment with a favorable prognosis and low rates of recurrence.PMID:37810306 | PMC:PMC10559383 | DOI:10.25259/SNI_646_2023 (Source: Surgical Neurology International)
Source: Surgical Neurology International - October 9, 2023 Category: Neurosurgery Authors: Abdulaziz M Alghamdi Abdulkarim M Alghamdi Alaa Samkari Afnan Samman Ahmed Lary Source Type: research
